Davenport & Co’s West Pharmaceutical WST Stock Holding History

Davenport & Co’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.84M	Sell	10,362 -360	-3%	-$127K	0.02%	432
2026 Q2	$3.85M	Buy	10,722 +1,642	+18%	+$502K	0.02%	425
2026 Q1	$2.28M	Sell	9,080 -441	-5%	-$110K	0.01%	498
2025 Q4	$2.62M	Buy	9,521 +8,078	+560%	+$2.21M	0.01%	471
2025 Q3	$379K	Sell	1,443 -905	-39%	-$220K	﹤0.01%	989
2025 Q2	$514K	Buy	2,348 +118	+5%	+$25.2K	﹤0.01%	866
2025 Q1	$499K	Buy	2,230 +1,136	+104%	+$313K	﹤0.01%	840
2024 Q4	$358K	Buy	1,094 +309	+39%	+$97.2K	﹤0.01%	945
2024 Q3	$236K	Buy	785 +54	+7%	+$16.5K	﹤0.01%	1058
2024 Q2	$241K	Sell	731 -88	-11%	-$31.1K	﹤0.01%	1027
2024 Q1	$324K	Buy	+819	New	+$303K	﹤0.01%	923
2021 Q4	–	Sell	-574	Closed	-$244K	–	1123
2021 Q3	$244K	Buy	+574	New	+$242K	﹤0.01%	924

Other funds holding WST

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 16.58% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Davenport & Co's WST Position: Q3 2026 in Review

Davenport & Co reduced its West Pharmaceutical (WST) stake by 3.4% in Q3 2026, selling an estimated $127K and leaving 10,362 shares worth $3.84M. The position accounts for 0.02% of the portfolio, ranked #432.

Davenport & Co first reported a position in WST in Q3 2021 and has held it in 12 quarters since. The position peaked at $3.85M in Q2 2026. 290 funds tracked by Wall St. Rank hold WST as of Q3 2026.

Davenport & Co held 10,362 shares of West Pharmaceutical worth $3.84M as of Q3 2026.
Davenport & Co sold 360 West Pharmaceutical shares in Q3 2026, an estimated $127K.
West Pharmaceutical made up 0.02% of Davenport & Co's portfolio in Q3 2026, its #432 holding.
Davenport & Co first reported a position in West Pharmaceutical in Q3 2021 and has held it in 12 quarters since.
Davenport & Co's West Pharmaceutical position peaked at $3.85M in Q2 2026.
290 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Davenport & Co's 13F filing for Q3 2026, filed 14 Oct 2026.